Search Results - "LADENSON, P. W"

The Impact of Age and Gender on Papillary Thyroid Cancer Survival by Jonklaas, J, Nogueras-Gonzalez, G, Munsell, M, Litofsky, D, Ain, K. B, Bigos, S. T, Brierley, J. D, Cooper, D. S, Haugen, B. R, Ladenson, P. W, Magner, J, Robbins, J, Ross, D. S, Skarulis, M. C, Steward, D. L, Maxon, H. R, Sherman, S. I, from the National Thyroid Cancer Treatment Cooperative Study Group

“…Context: Thyroid cancer predominately affects women, carries a worse prognosis in older age, and may have higher mortality in men. Superimposed on these…”
Get full text

Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study by Pacini, F., Ladenson, P. W., Schlumberger, M., Driedger, A., Luster, M., Kloos, R. T., Sherman, S., Haugen, B., Corone, C., Molinaro, E., Elisei, R., Ceccarelli, C., Pinchera, A., Wahl, R. L., Leboulleux, S., Ricard, M., Yoo, J., Busaidy, N. L., Delpassand, E., Hanscheid, H., Felbinger, R., Lassmann, M., Reiners, C.

“…Context: After surgery for differentiated thyroid carcinoma, many patients are treated with radioiodine to ablate remnant thyroid tissue. This procedure has…”
Get full text

A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma by Mazzaferri, E. L., Robbins, R. J., Spencer, C. A., Braverman, L. E., Pacini, F., Wartofsky, L., Haugen, B. R., Sherman, S. I., Cooper, D. S., Braunstein, G. D., Lee, S., Davies, T. F., Arafah, B. M., Ladenson, P. W., Pinchera, A.

“…Recent studies have provided new information regarding the optimal surveillance protocols for low-risk patients with differentiated thyroid cancer (DTC). This…”
Get full text

Assessment of the Incremental Value of Recombinant Thyrotropin Stimulation before 2-[18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Imaging to Localize Residual Differentiated Thyroid Cancer by Leboulleux, S., Schroeder, P. R., Busaidy, N. L., Auperin, A., Corone, C., Jacene, H. A., Ewertz, M. E., Bournaud, C., Wahl, R. L., Sherman, S. I., Ladenson, P. W., Schlumberger, M.

“…Purpose: The purpose of the study was to assess prospectively the impact of recombinant human TSH (rhTSH) administration on positron emission tomography…”
Get full text

BRAF T1796A Transversion Mutation in Various Thyroid Neoplasms by Xing, M., Vasko, V., Tallini, G., Larin, A., Wu, Gujun, Udelsman, R., Ringel, M. D., Ladenson, P. W., Sidransky, D.

“…A high prevalence of activating mutation of the B type Raf kinase (BRAF) gene was recently reported in papillary thyroid cancer (PTC). However, the frequency…”
Get full text

BRAF Mutation in Papillary Thyroid Carcinoma by Cohen, Yoram, Xing, Mingzhao, Mambo, Elizabeth, Guo, Zhongmin, Wu, Guogun, Trink, Barry, Beller, Uziel, Westra, William H., Ladenson, Paul W., Sidransky, David

“…The BRAF gene has been found to be activated by mutation in human cancers, predominantly in malignant melanoma. We tested 476 primary tumors, including 214…”
Get full text

Effects of the Thyromimetic Agent Diiodothyropropionic Acid on Body Weight, Body Mass Index, and Serum Lipoproteins: A Pilot Prospective, Randomized, Controlled Study by Ladenson, P. W, McCarren, M, Morkin, E, Edson, R. G, Shih, Mei-Chiung, Warren, S. R, Barnhill, J. G, Churby, L, Thai, H, O'Brien, T, Anand, I, Warner, A, Hattler, B, Dunlap, M, Erikson, J, Goldman, S

“…Context: Widespread thyroid hormone actions offer the possibility of developing selective thyromimetic analogs with salutary metabolic properties…”
Get full text

Follow-Up of Low-Risk Differentiated Thyroid Cancer Patients Who Underwent Radioiodine Ablation of Postsurgical Thyroid Remnants after Either Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal by Elisei, R., Schlumberger, M., Driedger, A., Reiners, C., Kloos, R. T., Sherman, S. I., Haugen, B., Corone, C., Molinaro, E., Grasso, L., Leboulleux, S., Rachinsky, I., Luster, M., Lassmann, M., Busaidy, N. L., Wahl, R. L., Pacini, F., Cho, S. Y., Magner, J., Pinchera, A., Ladenson, P. W.

“…Background: We previously demonstrated comparable thyroid remnant ablation rates in postoperative low-risk thyroid cancer patients prepared for administration…”
Get full text

Controversies in the follow-up and management of well-differentiated thyroid cancer by Ringel, M D, Ladenson, P W

“…Thyroid cancer is a common malignancy with an apparent increasing incidence and a wide spectrum of clinical behavior and therapeutic responsiveness. Recent…”
Get full text

Hypothyroidism in pregnancy: consequences to neonatal health by Smallridge, R C, Ladenson, P W

Get full text

Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma by Ladenson, Paul W, Braverman, Lewis E, Mazzaferri, Ernest L, Brucker-Davis, Françoise, Cooper, David S, Garber, Jeffrey R, Wondisford, Fredric E, Davies, Terry F, DeGroot, Leslie J, Daniels, Gilbert H, Ross, Douglas S, Weintraub, Bruce D, Hay, Ian D, Levis, Silvina, Reynolds, James C, Robbins, Jacob, Becker, David V, Cavalieri, Ralph R, Maxon, Harry R, McEllin, Kevin, Moscicki, Richard

“…Thyroid carcinoma is diagnosed in 14,000 people each year in the United States. 1 Most are effectively treated by surgery, followed often by radioiodine…”
Get full text

Risk of Thyroid Cancer Among Solid Organ Transplant Recipients by Kitahara, C. M., Yanik, E. L., Ladenson, P. W., Hernandez, B. Y., Lynch, C. F., Pawlish, K. S., Engels, E. A.

“…Solid organ transplant recipients have an elevated incidence of thyroid cancer. We evaluated a wide range of potential risk factors in a cohort of 229 300 U.S…”
Get full text

Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood by RINGEL, M. D, LADENSON, P. W, LEVINE, M. A

“…Serum thyroglobulin measurement by immunoassay is used to detect residual or recurrent thyroid cancer after thyroid ablation. However, the usefulness of…”
Get full text

Hürthle cell neoplasms of the thyroid : Are there factors predictive of malignancy? by CHEN, H, NICOL, T. L, ZEIGER, M. A, DOOLEY, W. C, LADENSON, P. W, COOPER, D. S, RINGEL, M, PARKERSON, S, ALLO, M, UDELSMAN, R

“…To determine if any preoperative or intraoperative factors can reliably predict malignancy in patients with Hürthle cell neoplasms. Most experienced surgeons…”
Get full text

Screening for Mild Thyroid Failure at the Periodic Health Examination: A Decision and Cost-effectiveness Analysis by Danese, Mark D, Powe, Neil R, Sawin, Clark T, Ladenson, Paul W

“…Objective.—To estimate the cost-effectiveness of periodic screening for mild thyroid failure by measurement of serum thyroid stimulating hormone (TSH)…”
Get full text

Three-Dimensional Radiobiologic Dosimetry: Application of Radiobiologic Modeling to Patient-Specific 3-Dimensional Imaging-Based Internal Dosimetry by Prideaux, Andrew R, Song, Hong, Hobbs, Robert F, He, Bin, Frey, Eric C, Ladenson, Paul W, Wahl, Richard L, Sgouros, George

“…Phantom-based and patient-specific imaging-based dosimetry methodologies have traditionally yielded mean organ-absorbed doses or spatial dose distributions…”
Get full text

When to treat mild hypothyroidism by Ayala, A R, Danese, M D, Ladenson, P W

“…The availability and wide acceptance of TSH assays for primary assessment of thyroid function has led to the recognition that mild thyroid hormone deficiency…”
Get more information

Reversible Alterations in Myocardial Gene Expression in a Young Man with Dilated Cardiomyopathy and Hypothyroidism by Ladenson, Paul W., Sherman, Steven I., Baughman, Kenneth L., Ray, Phillip E., Feldman, Arthur M.

“…Thyroid hormone effects on myocardial gene expression have been well defined in animal models, but their relationship to the pathogenesis of cardiac…”
Get full text

Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma by Sherman, S I, Tielens, E T, Sostre, S, Wharam, Jr, M D, Ladenson, P W

“…A retrospective comparison was performed of whole body scans obtained before and after 143 131I treatments in 93 patients with thyroid carcinoma. Pretreatment…”
Get more information

Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma by RINGEL, M. D, BALDUCCI-SILANO, P. L, LEVINE, M. A, TUTTLE, R. M, ANDERSON, J. S, SPENCER, C. A, SILVERMAN, J, SPARLING, Y. H, FRANCIS, G. L, BURMAN, K. D, WARTOFSKY, L, LADENSON, P. W

“…Patients with thyroid cancer are monitored for disease recurrence by measurement of serum thyroglobulin (Tg) and iodine-131 (131I) scanning. To enhance…”
Get full text